Clinical Trials
Our lead candidate, ANG003, is currently being investigated in a large international Phase 2 study in people with cystic fibrosis and exocrine pancreatic insufficiency (NCT07450547). Learn more about the study at clin trials.gov.
“We all work hard at Anagram. However, no one works harder than the people who participate in our studies. Their strength — and that of their families — is what motivates us.”
